stem-cell therapies blood diseases 
decades transplantation haematopoietic stem cells-either unmodified genetically modified correct genetic disorders-has used treat disorders blood immune systems present challenge reduce risk transplants increase number patients can safely access treatment developing countries one-shot treatments highly desirable chronic treatments difficult sustain make therapies accessible effective will important improve clinical protocols gene-delivery vectors gain deeper understanding stem cells 
